Ceftazidime-avibactam: monotherapy or combination therapy to treat carbapenem resistant gram-negative infections ? ( Onorato L. et al. )
Efficacy of ceftazidime-avibactam in monotherapy or combination therapy against carbapenem resistant gram negative organisms: a meta-analysis
| Dr Jean-Pierre Bru Ceftazidime/avibactam, display in vitro activity against strains producing class-A-carbapenemases, including Klebsiella pneumoniae (KPC), as well as some class-D-carbapenemases, Some recent … Suite